Literature DB >> 24599455

Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects.

Estefanía Moreno1, David Moreno-Delgado, Gemma Navarro, Hanne M Hoffmann, Silvia Fuentes, Santi Rosell-Vilar, Paola Gasperini, Mar Rodríguez-Ruiz, Mireia Medrano, Josefa Mallol, Antoni Cortés, Vicent Casadó, Carme Lluís, Sergi Ferré, Jordi Ortiz, Enric Canela, Peter J McCormick.   

Abstract

The general effects of cocaine are not well understood at the molecular level. What is known is that the dopamine D1 receptor plays an important role. Here we show that a key mechanism may be cocaine's blockade of the histamine H3 receptor-mediated inhibition of D1 receptor function. This blockade requires the σ1 receptor and occurs upon cocaine binding to σ1-D1-H3 receptor complexes. The cocaine-mediated disruption leaves an uninhibited D1 receptor that activates Gs, freely recruits β-arrestin, increases p-ERK 1/2 levels, and induces cell death when over activated. Using in vitro assays with transfected cells and in ex vivo experiments using both rats acutely treated or self-administered with cocaine along with mice depleted of σ1 receptor, we show that blockade of σ1 receptor by an antagonist restores the protective H3 receptor-mediated brake on D1 receptor signaling and prevents the cell death from elevated D1 receptor signaling. These findings suggest that a combination therapy of σ1R antagonists with H3 receptor agonists could serve to reduce some effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599455      PMCID: PMC3942573          DOI: 10.1523/JNEUROSCI.4147-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair.

Authors:  Timo Zimmermann; Jens Rietdorf; Andreas Girod; Virginie Georget; Rainer Pepperkok
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

Review 2.  Sigma-1 receptors: potential targets for the treatment of substance abuse.

Authors:  Matthew J Robson; Bahar Noorbakhsh; Michael J Seminerio; Rae R Matsumoto
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.

Authors:  Vincent Casadó; Antoni Cortés; Francisco Ciruela; Josefa Mallol; Sergi Ferré; Carmen Lluis; Enric I Canela; Rafael Franco
Journal:  Pharmacol Ther       Date:  2007-06-14       Impact factor: 12.310

4.  Unbalanced neuronal circuits in addiction.

Authors:  Nora D Volkow; Gen-Jack Wang; Dardo Tomasi; Ruben D Baler
Journal:  Curr Opin Neurobiol       Date:  2013-02-21       Impact factor: 6.627

5.  beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.

Authors:  Sudha K Shenoy; Matthew T Drake; Christopher D Nelson; Daniel A Houtz; Kunhong Xiao; Srinivasan Madabushi; Eric Reiter; Richard T Premont; Olivier Lichtarge; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2005-11-09       Impact factor: 5.157

Review 6.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 7.  Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.

Authors:  Teresa Cunha-Oliveira; Ana Cristina Rego; Catarina R Oliveira
Journal:  Brain Res Rev       Date:  2008-03-27

8.  Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling.

Authors:  Kicheon Park; Nora D Volkow; Yingtian Pan; Congwu Du
Journal:  J Neurosci       Date:  2013-10-02       Impact factor: 6.167

9.  Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice.

Authors:  M Xu; X T Hu; D C Cooper; R Moratalla; A M Graybiel; F J White; S Tonegawa
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

Review 10.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

View more
  26 in total

Review 1.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

2.  Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.

Authors:  Xavier Guitart; Gemma Navarro; Estefania Moreno; Hideaki Yano; Ning-Sheng Cai; Marta Sánchez-Soto; Sandeep Kumar-Barodia; Yamini T Naidu; Josefa Mallol; Antoni Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Peter J McCormick; Sergi Ferré
Journal:  Mol Pharmacol       Date:  2014-08-05       Impact factor: 4.436

Review 3.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

4.  (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.

Authors:  Julie A Meade; R Benjamin Free; Nicole R Miller; Lani S Chun; Trevor B Doyle; Amy E Moritz; Jennie L Conroy; Val J Watts; David R Sibley
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

5.  Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells.

Authors:  Liliana Galindo; Estefanía Moreno; Fernando López-Armenta; Daniel Guinart; Aida Cuenca-Royo; Mercè Izquierdo-Serra; Laura Xicota; Cristina Fernandez; Esther Menoyo; José M Fernández-Fernández; Gloria Benítez-King; Enric I Canela; Vicent Casadó; Víctor Pérez; Rafael de la Torre; Patricia Robledo
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

6.  Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.

Authors:  Gemma Navarro; César Quiroz; David Moreno-Delgado; Adam Sierakowiak; Kimberly McDowell; Estefanía Moreno; William Rea; Ning-Sheng Cai; David Aguinaga; Lesley A Howell; Felix Hausch; Antonio Cortés; Josefa Mallol; Vicent Casadó; Carme Lluís; Enric I Canela; Sergi Ferré; Peter J McCormick
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

7.  Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways.

Authors:  Jeffrey L Barr; Elena Deliu; G Cristina Brailoiu; Pingwei Zhao; Guang Yan; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Cell Calcium       Date:  2015-05-27       Impact factor: 6.817

8.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

9.  Striatal Signaling Regulated by the H3R Histamine Receptor in a Mouse Model of tic Pathophysiology.

Authors:  Maximiliano Rapanelli; Luciana Frick; Kantiya Jindachomthong; Jian Xu; Hiroshi Ohtsu; Angus C Nairn; Christopher Pittenger
Journal:  Neuroscience       Date:  2018-09-29       Impact factor: 3.590

10.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.